海外の治験の状況「前立腺癌」での検索結果
118件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTRIC STUDY TO EVALUATE THE EFFECTS OF ROFECOXIB IN REDUCING THE RISK OF PROSTATE CANCER (VIP STUDY).
- -C61 Malignant neoplasm of prostate Malignant neoplasm of prostate;Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Costa Rica, Czech Republic, Denmark, Finland, France, Germany, Greece, Israel, Italy, Netherlands, New Zealand, Portugal, Singapore, Sweden, Switzerland, United Kindgdom, United States, Venezuela
- 2003-08-28
Not recruiting
- ODM-201 in Addition to Standard ADT and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
- Prostatic Neoplasms
- Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Czechia, Finland, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2016-06-06
Not recruiting
- Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Brazil, China, Korea, Republic of, Kuwait, Lebanon, New Zealand, Saudi Arabia, Taiwan, Thailand
- 2005-10-19
Not recruiting
- A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
- Prostate Cancer;Castration-resistant Prostate Cancer;Metastatic Prostate Cancer
- Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, France, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, United Kingdom
- 2014-02-18
Not recruiting
- Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
- Hormone Sensitive Prostate Cancer;Prostate Cancer;Cancer of the Prostate
- Australia, Austria, Brazil, Canada, Denmark, Finland, France, Italy, Korea, Republic of, Netherlands, Poland, Slovakia, Spain, Sweden, Taiwan, United Kingdom, United States
- 2014-12-14
Not recruiting
- Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy
- Prostate Cancer;Prostate Cancer;Prostate Cancer
- Brazil
- 2013-03-12
Not recruiting
- A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, France, Germany, Hungary, India, Italy, Korea, Republic of, Netherlands, Norway, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2008-01-24
Not recruiting
- A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Finland, Former Serbia and Montenegro, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Mexico, Netherlands, Norway, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2008-01-24
Not recruiting
- Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Czech Republic, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Peru, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2010-08-31
Not recruiting
- Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial
- Prostatic Neoplasms
- Brazil
- 2014-11-03